TORONTO, ON / ACCESSWIRE / November 25, 2020 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital" or "Sparta") has secured two noteworthy orders just weeks after forming its Sparta Health Group division ("Sparta Health"), thus answering the call for immediate help with Personal Protective Equipment ("PPE") due to COVID-19.

With the initial intent to develop a program utilizing proper process control engineering principles to help streamline the purchasing of PPE, Sparta's Healthcare division has also been able to facilitate significant initial orders to supply Canadian health-care facilities with some 10 million pairs of medical-grade gloves. The $2.5 million worth of imported gloves will go a long way in helping protect staff in healthcare facilities in Calgary and Toronto.

"When we set up our PPE purchasing system with Motocitee Industries, we felt we had the right partner and the right processes to give facilities in need a better chance at attaining supplies. And now we can safely say that it really feels good to know that our system is already helping the people who need it the most," said Sparta President and Chief Technology Officer, John O'Bireck.

On November 5th, Sparta announced that it would be expanding its COVID-19 Safety efforts by forming Sparta Health Group Ltd. ("Sparta Health") and partnering with Health Canada approved supplier, Motocitee Industries Inc. Since that time, Sparta has been fielding many inquiries about PPE, including gloves.

The Centers for Disease Control and Prevention ("CDC") reports that in addition to face masks, disposable gloves are an important tool in protecting yourself from COVID-19, especially if you work in the healthcare sector. Unfortunately, much like hand sanitizer being in short supply at the beginning of the pandemic, disposable gloves have become harder for people to find. Due to the formation of the Sparta Health Group those who need PPE the most, such as hospital and long-term care staff, now have easier access to supplies since traditional slow-downs in the purchase-to-delivery process are not a factor.

"Since the formation of Sparta Health, and the collaboration between Motocitee and the Sparta team, it has become very apparent that the strategic partnership is already accelerating the ability to get these PPE products into the hands of people who need them," added Jason Smith, Managing Director of Sparta Health.

As more orders come in, Sparta Health will continue to distribute its previously announced line of pathogen protection formulations. Over the summer Sparta's natural, alcohol free, non-toxic antimicrobial spray was demonstrated at a church in Woodbridge and garnered significant media attention. This after the Company announced it was distributing the protectant to the trucking industry – specifically to safeguard the inside of truck cabs. Since interest is growing, Sparta is looking at expanding its line of environment-safe pathogen protection technologies to provide microbe control in a number of sectors, including offices, medical facilities, and factories.

"Sparta is and always will be an environmental company focused on upcycling waste and optimizing energy. But there are times when companies like ours need to pivot to help the workforce get through difficult times and this is one of those times in our history," said O'Bireck.

About Sparta™

Sparta Group (a.k.a. Sparta Capital Ltd.) is a technology-based company that owns or holds a controlling interest in a network of independent businesses that supply energy saving technologies designed to reduce energy inefficiencies, achieve reduced emissions and increase operating efficiencies in various industries. In response to the COVID-19 crisis, Sparta has also expanded its scope to help facilitate supply of necessary materials while assisting talented inventors who are looking to introduce innovative technical solutions that will bring greater normalcy to the post COVID-19 world. Sparta's network of independent businesses provides a wide range of specialized energy capturing, converting, optimizing, and related services to the commercial sector. Sparta provides capital, technical and engineering expertise, legal support, financial and accounting knowledge, strategic planning and other shared services to its independent businesses.

Sparta is a publicly traded company listed on the TSX Venture Exchange Inc. under the symbol "SAY" (TSX.V: SAY). Additional information is available at www.spartagroup.ca or on SEDAR at www.sedar.com.

For further information please contact:

John O'Bireck, President & CTO
Email: jobireck@spartagroup.ca
Telephone: (905) 751-8004

Cautionary Statements:

This news release contains "forward-looking information" within the meaning of applicable securities laws. When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Corporation can give no assurance that they will prove to be correct. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this news release and the Corporation undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Corporation undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Corporation. These include, but are not limited to, the failure to obtain necessary regulatory approvals, necessary financing and risks associated with the environmental technologies industry in general. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Sparta Group

ReleaseID: 618330

NOBLESVILLE, IN / ACCESSWIRE / November 25, 2020 / A group of concerned citizens of Noblesville is asking Mayor Chris Jensen to take time to evaluate his suggested alternative route to extend Pleasant Street west over the White River. The Noblesville Bypass Coalition charges that the Mayor's plan would add an unnecessary roundabout and force a major employer out of Noblesville. Their campaign is called "Pick The Right Route."

The Coalition is being led by IDI Composites International, a high tech manufacturer in Noblesville, and its employees who say they will have no choice but to move from their current location on 7th Street where they have been for over 50 years. Mayor Jensen is proposing a new alternative to the Pleasant St. Extension called B1 that adds a second roundabout within 100 yards of the first roundabout at 8th St. and then cuts through IDI's campus. The Coalition supports an extension of Pleasant St. to reduce traffic through downtown Noblesville, but they do not believe the Mayor has taken enough time to evaluate his suggested route to find the best alternative. The B-1 alternative route is intended to go around the newly designated historic neighborhood of Plum Prairie.

"We believe there are better alternatives to what the Mayor is suggesting, but he seems unwilling to listen to his constituents to find the best solution," said Tom Merrell, President and CEO of IDI Composites International. "We value our community and we want to stay in Noblesville. But if Mayor Jensen's plan is approved, we will be forced to move our facility in which we have invested over $15 million since 2012. The Mayor's Pleasant Street Extension design ruins both the functionality of our operations and the desired visual aesthetic we wish to convey to our high-tech, Fortune 500 visitors from around the globe."

IDI Composites International, which began in 1966, employs almost 100 people at its manufacturing, research & development and world headquarters in Noblesville at an average salary of $73,000 plus benefits. The Company has said that it likely would not relocate in Noblesville due to the high cost. IDI has also contributed over $1 million dollars in community and civic projects in recent years.

Members of the Coalition attended a Community Advisory Committee meeting on November 12 where consultants for the City presented its B-1 alternative route. Despite a number of questions and concerns from the audience, the consultants indicated that they had already settled on their suggested route. The Coalition is asking the Mayor to slow down and study the best alternative rather than rush to get the B-1 route approved.

For more information, go to the Coalition's website at www.PickTheRightRoute.com.

Media Contact

Kevin Flynn
(317)213-7799
kflynn@cvrindy.com

SOURCE: Noblesville Bypass Coalition

ReleaseID: 618323

JACKSON CENTER, PA / ACCESSWIRE / November 25, 2020 / Halberd Corporation (OTC PINK:HALB) Chairman, President and CEO, William A. Hartman, was interviewed this week by host, Donald Baillargeon, on Money TV. Mr. Hartman recapped the company's accomplishments, describing its most promising technologies and described the unique applications perceived, including a sneak peek at the future.

Mr. Hartman detailed some of the most recent developments in Halberd's top priority research: to develop products which should facilitate diagnostic, prevention and treatment of Covid-19. This includes:

Three issued patents;
Six provisional patent applications;
Two unique Covid-19 antibodies;
Nasal spray preventative alternative to Covid-19 vaccine (under development);
Patent-pending fluorescent antibody for rapid Covid-19 diagnostic test (under development).

Mr. Hartman also explained the plans to fund its R&D through a Section 501(c)(3) charitable organization, and/or through one or more joint ventures with established pharmaceutical companies to expedite Halberd's products to market.

Future plans include possible listing the company on foreign stock markets utilizing foreign subsidiaries, such as the one currently established in the UK.

You can view the entire interview video here.

If you would like to be added to our email subscriber list, click here and submit the form.

For more information please contact:
William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
P. O. Box 25
Jackson Center, PA 16133
Twitter:@HalberdC

About Halberd Corporation.
Halberd Corporation. (OTC PINK:HALB), is a publicly-traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. Halberd's Articles of Incorporation prohibit the company from issuance of convertible debt which would result in dilution. See the company's Articles of Incorporation here.

The company holds the exclusive rights to the COVID-19 extracorporeal treatment technology provisional patent applications: "Method for Treating and Curing Covid-19 Infection;" "Method for Treating COVID-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in COVID-19 Patients;" "Method for Treating and Curing COVID-19 Infection by Utilizing a Laser to Eradicate the Virus," and, "Nasal Spray To Prevent The Transmission Of Covid-19 Between Humans," "Nasal Spray to Prevent the Transmission of Covid-19," and "Method For Treating And Curing Covid-19 Infection By Utilizing Radiofrequency Extracorporeally To Eradicate The Virus." Halberd also holds the exclusive rights to the underlying granted U.S. Patent 9,216,386 and U.S. Patent 8,758,287.

Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.

Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives –
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.

The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment or other strategies with regard to COVID-19.

The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.

We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be adverse to the pecuniary interests of the Company and of its shareholders.

SOURCE: Halberd Corporation

ReleaseID: 618317

Advisory Board will be comprised of leading experts with diverse industry backgrounds supporting Carbon, Metals and Critical / Rare Earth

Randal Stephenson, a 3-year member of the Company's Board of Directors, will transition to assist and guide the Advisory Board as its inaugural member

FISHERS, IN / ACCESSWIRE / November 25, 2020 / American Resources Corporation (NASDAQ:AREC) ("American Resources" or the "Company"), a next generation and socially responsible supplier of raw materials to the new infrastructure marketplace, today announced the formation of a Strategic Advisory Board to aid in the advancement of its streamlined and efficient operations to economically deliver raw materials products through leveraging expertise of diverse industry backgrounds. The Strategic Advisory Board function is an informal committee that will assist the Company in its overall development and growth as well as strengthening its specific industry footprints. The goal of the Advisory Board is to provide relationship support, industry support and overall guidance and insights into American Resources' growth cycles of all three divisions.

Randal Stephenson, a valued member of the Company's Board of Directors, will transition as the founding member of the Strategic Advisory Board to lead and guide its development. As a member of the Company's Board for the last three years, Mr. Stephenson has played an instrumental role in helping guide American Resources through its public offering as well as capital raising the Company has achieved to-date.

Mark Jensen, Chairman and CEO of American Resources Corporation commented, "We are very excited to expand our capabilities, team and knowledge base with the creation of our Strategic Advisory Board. As a member of our Board over the course of the past three years, Randal played a hand in the growth of American Resources into a diversified producer of metallurgical carbon, metal recycling and critical / rare earth element development. He has proven to be a team player that has helped the Company through multiple acquisitions, financings and restructurings over the years, and we're excited to have someone of his caliber lead this important initiative. As we continue to speak with and seek additional members to bolster the knowledge and expertise of this Strategic Advisory Board, we look forward to building on the momentum and unlocking the potential for innovation and modernization of our industry."

American Resources will look to add individuals that can provide expertise and guidance as it advances at the holding company level as well as the three divisions described below:

American Carbon – A producer and processor of met carbon, PCI and stoker products to the new steel and infrastructure marketplace. The Company puts a large emphasis on efficiencies within its operations to ensure a low cost, high quality production base for many generations to come.

American Metals – An aggregator and processor of used steel primarily for the electric arc furnace marketplace. The Company is focused on establishing efficient supply chains to provide its customer base high volumes of processed steel, largely from sources that no longer fits a modern day economy, to be recycled into new steel for a variety of purposes.

American Rare Earth – An environmentally positive solution to the production, concentration and processing of critical and rare earth elements. The division is focused on restoring the rare earth supply chain back to the United States in the most cost effective, environmentally positive and socially conscious way. The division plans on producing and selling rare earth concentrate in the 2021 fiscal year with the goal of building the first processing facility in the eastern part of the U.S. to process to the element level.

American Resources Corporation is focused on running a streamlined and efficient operation to economically deliver raw materials products to meet its customers' demands. By operating with low or no legacy costs and having one of the largest and most innovative growth pipelines in the industry, American Resources Corporation works to maximize value for its investors while being able to scale its operations to meet the growth of the markets it serves.

About American Resources Corporation
American Resources Corporation is a supplier of high-quality raw materials to the rapidly growing global infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking. American Resources has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon deposits are concentrated.

American Resources has established a nimble, low-cost business model centered on growth, which provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure market while also continuing to acquire operations and significantly reduce their legacy industry risks. Its streamlined and efficient operations are able to maximize margins while reducing costs. For more information visit americanresourcescorp.com or connect with the Company on Facebook, Twitter, and LinkedIn.

Special Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the Company's actual results, performance, or achievements or industry results to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are subject to a number of risks and uncertainties, many of which are beyond American Resources Corporation's control. The words "believes", "may", "will", "should", "would", "could", "continue", "seeks", "anticipates", "plans", "expects", "intends", "estimates", or similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Any forward-looking statements included in this press release are made only as of the date of this release. The Company does not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent events or circumstances. The Company cannot assure you that the projected results or events will be achieved.

PR Contact:
Precision Public Relations
Matt Sheldon
17-280-7329
matt@precisionpr.co

Investor Contact:
JTC Team, LLC
Jenene Thomas
833-475-8247
AREC@jtcir.com

Company Contact:
Mark LaVerghetta
317-855-9926 ext. 0
Vice President of Corporate Finance and Communications
investor@americanresourcescorp.com

SOURCE: American Resources Corporation

ReleaseID: 618292

Posts Record Quarterly EBITDA

TORONTO, ON / ACCESSWIRE / November 25, 2020 / Route1 Inc. (OTCQB:ROIUF)(TSXV:ROI) (the "Company" or "Route1"), an advanced North American provider of data-centric business empowerment solutions, today reported its financial results for the three- and nine-month periods ended September 30, 2020.

Statement of operations

In 000s of CAD dollars

 
 
Q32020
 
 
 
Q22020
 
 
 
Q12020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Revenue

Subscription and services

 
 
2,599
 
 
 
2,489
 
 
 
1,958
 
 
 
2,511
 
 
 
2,136
 
 
 
1,610
 

Devices and appliances

 
 
6,523
 
 
 
4,477
 
 
 
4,401
 
 
 
5,891
 
 
 
6,576
 
 
 
1,819
 

Other

 
 
25
 
 
 
3
 
 
 
4
 
 
 
1
 
 
 
2
 
 
 
1
 

Total revenue

 
 
9,147
 
 
 
6,969
 
 
 
6,363
 
 
 
8,403
 
 
 
8,714
 
 
 
3,430
 

Cost of revenue

 
 
6,134
 
 
 
4,188
 
 
 
3,997
 
 
 
5,653
 
 
 
5,953
 
 
 
1,672
 

Gross profit

 
 
3,013
 
 
 
2,781
 
 
 
2,366
 
 
 
2,750
 
 
 
2,761
 
 
 
1,758
 

Operating expenses

 
 
2,562
 
 
 
2,570
 
 
 
2,334
 
 
 
2,360
 
 
 
2,336
 
 
 
1,824
 

Operating profit (loss) 1

 
 
451
 
 
 
211
 
 
 
32
 
 
 
390
 
 
 
425
 
 
 
(66
)

Total other expenses 2, 3, 4

 
 
979
 
 
 
271
 
 
 
215
 
 
 
(120
)
 
 
424
 
 
 
487
 

Net income (loss)

 
 
(528
)
 
 
(60
)
 
 
(183
)
 
 
510
 
 
 
1
 
 
 
(553
)

1 Before stock-based compensation

2 Includes stock-based compensation, AirWatch litigation, gain on acquisition and foreign exchange

3 The reimbursements received from Bench Walk pursuant to its investment have been accounted for as a long-term non-monetary liability within the consolidated financial statements, not as a reduction to patent litigation expense. All such amounts are non-recourse to the Company. In connection with the terms of the agreement, the Company does not have a present obligation to pay any amounts until such time as the litigation has been settled or an event of default has occurred. In the event of an award or settlement of the litigation, the Company will be obligated to pay Bench Walk the greater of 10% of such award or settlement and $2,000,000 or $3,000,000 if the litigation proceeds to trial.

4 In the third quarter of 2020, the Company incurred Total Other Expenses of approximately $1.0 million. The largest components are: (a) gain on settlement of litigation of $0.2 million, (b) AirWatch litigation expenses and costs related to posting the fully cash-collateralized bond of $0.4, and (c) a reserve for $0.6 million related to the recovery of goods fraudulently taken from Route1. The Company was the victim of a fraud in the United States perpetrated by a group posing as legitimate customers with the goal of purchasing rugged devices. The Company has paid its vendor of record the full amount and has no further financial obligations. The Company has been in contact with its insurers but there is no assurance the Company will receive any amount of compensation.

Subscription and services revenue

in 000s of CAD dollars

 
 
Q32020
 
 
 
Q2
2020
 
 
 
Q12020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Application software

 
 
1,923
 
 
 
1,665
 
 
 
1,217
 
 
 
1,202
 
 
 
1,182
 
 
 
1,196
 

Technology as a service (TaaS)

 
 
241
 
 
 
315
 
 
 
321
 
 
 
353
 
 
 
322
 
 
 
311
 

Other services

 
 
435
 
 
 
509
 
 
 
420
 
 
 
956
 
 
 
632
 
 
 
103
 

Total

 
 
2,599
 
 
 
2,489
 
 
 
1,958
 
 
 
2,511
 
 
 
2,136
 
 
 
1,610
 

Adjusted EBITDA

in 000s of CAD dollars

 
 
Q32020
 
 
 
Q22020
 
 
 
Q1
2020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Gross Profit

 
 
3,013
 
 
 
2,781
 
 
 
2,366
 
 
 
2,750
 
 
 
2,761
 
 
 
1,758
 

Adjusted EBITDA 5

 
 
778
 
 
 
556
 
 
 
358
 
 
 
676
 
 
 
743
 
 
 
200
 

Amortization

 
 
327
 
 
 
346
 
 
 
326
 
 
 
286
 
 
 
318
 
 
 
266
 

Operating profit (loss)

 
 
451
 
 
 
211
 
 
 
32
 
 
 
390
 
 
 
425
 
 
 
(66
)

5 Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, stock-based compensation, patent litigation, restructuring and other costs. Adjusted EBITDA does not have any standardized meaning prescribed under IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. Adjusted EBITDA allows Route1 to compare its operating performance over time on a consistent basis.

Balance sheet extracts

In 000s of CAD dollars

Sep 30

2020

Jun 30

2020

Mar 31

2020

Dec 31

2019

Sep 30

2019

Jun 30

2019

Cash

 
 
–
 
 
 
107
 
 
 
116
 
 
 
126
 
 
 
320
 
 
 
702
 

Total current assets 6

 
 
8,836
 
 
 
5,448
 
 
 
4,391
 
 
 
6,206
 
 
 
6,106
 
 
 
6,219
 

Total current liabilities

 
 
13,385
 
 
 
8,901
 
 
 
7,532
 
 
 
9,035
 
 
 
8,749
 
 
 
8,625
 

Net working capital

 
 
(4,549
)
 
 
(3,453
)
 
 
(3,141
)
 
 
(2,829
)
 
 
(2,643
)
 
 
(2,406
)

Net working capital adjusted for contract liability

 
 
490
 
 
 
800
 
 
 
(1,570
)
 
 
(1,078
)
 
 
(221
)
 
 
(149
)

Total assets

 
 
15,749
 
 
 
12,283
 
 
 
11,501
 
 
 
12,630
 
 
 
11,780
 
 
 
12,268
 

Bank debt and seller notes

 
 
2,609
 
 
 
1,193
 
 
 
2,461
 
 
 
2,415
 
 
 
2,294
 
 
 
1,862
 

Total shareholders' equity 3

 
 
37
 
 
 
778
 
 
 
950
 
 
 
980
 
 
 
473
 
 
 
854
 

6 Included as at September 30, 2020 is restricted cash of US$1,669,840 (CAD $2,226,065) that allowed Route1 to post a cash-collateralized bond with the court in the same amount in connection with the Company's appeal of the United States District Court for the District of Delaware partial granting of AirWatch's motion for attorney's fees in the matter of Route1 Inc. v. AirWatch, LLC.

Net cash flow

In 000s of CAD dollars

 
 
Q32020
 
 
 
Q2
2020
 
 
 
Q12020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Cash generated in operating activities

 
 
1,523
 
 
 
1,773
 
 
 
472
 
 
 
64
 
 
 
20
 
 
 
965
 

Cash used in investing activities

 
 
(489
)
 
 
(240
)
 
 
(633
)
 
 
(174
)
 
 
(154
)
 
 
(1,303
)

Cash generated (used) in financing activities

 
 
1,092
 
 
 
(1,543
)
 
 
165
 
 
 
(28
)
 
 
(247
)
 
 
696
 

Net cash inflow (outflow)

 
 
2,126
 
 
 
(10
)
 
 
4
 
 
 
(138
)
 
 
(381
)
 
 
358
 

Business Update Conference Call and Webcast

The Company will hold a conference call and web cast to provide a business update on Wednesday, November 25, 2020 at 9:00 am eastern.

Participants should dial Toll-Free: 1-877-407-0781 or Toll/International: 1-201-689-8568 at least 10 minutes prior to the conference. For those unable to attend the call, a replay will be available on November 25, 2020 after 4 pm eastern at Toll-Free 1-877-481-4010 or Toll/International 1-919-882-2331, pass code #39006 until 10 am on Wednesday, December 2, 2020.

The webcast will be presented live at https://www.webcaster4.com/Webcast/Page/2167/39006.

About Route1 Inc.

Route1 Inc. is an advanced North American technology company that empowers their clients with data-centric solutions necessary to drive greater profitability, improve operational efficiency and gain sustainable competitive advantages, while always emphasizing a strong cybersecurity and information assurance posture. Route1 delivers exceptional client outcomes through real-time secure delivery of actionable intelligence to decision makers, whether it be in a manufacturing plant, in-theater or in a university parking lot. Route1 is listed on the OTCQB in the United States under the symbol ROIUF and in Canada on the TSX Venture Exchange under the symbol ROI. For more information, visit: www.route1.com.

For More Information, Contact:

Tony Busseri
President and Chief Executive Officer
+1 480 500-7030
tony.busseri@route1.com

This news release, required by applicable Canadian laws, does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

© 2020 Route1 Inc. All rights reserved. No part of this document may be reproduced, transmitted or otherwise used in whole or in part or by any means without prior written consent of Route1 Inc. See https://www.route1.com/terms-of-use/ for notice of Route1's intellectual property.

This news release may contain statements that are not current or historical factual statements that may constitute forward-looking statements or future oriented financial information. These statements are based on certain factors and assumptions, including, expectations regarding the success of the private placement and the terms on which the Company will raise funds, price and liquidity of the common shares, expected financial performance, expected subscribers and subscription-based revenue, business prospects, technological developments, development activities, the ability of the Company to obtain the supersedeas bond in order to appeal the decision to the United States Court of Appeals for the Federal Circuit, and like matters. While Route1 considers these factors and assumptions to be reasonable, based on information currently available, they may prove to be incorrect. These statements involve risks and uncertainties, including but not limited to the risk factors described in reporting documents filed by the Company. Actual results could differ materially from those projected as a result of these and other risks and should not be relied upon as a prediction of future events. The Company undertakes no obligation to update any forward-looking statement or future oriented financial information to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, except as required by law. Estimates used in this presentation are from Company sources. Past or forecasted performance is not a guarantee of future performance and readers should not rely on historical results or forward-looking statements or future oriented financial information as an assurance of future results.

SOURCE: Route1 Inc.

ReleaseID: 618285

Axon generated potential therapeutic antibodies that are able to neutralize the SARS-CoV-2 virus
In cooperation with the Virological Institute of Biomedical Research Center at the Slovak Academy of Sciences in Bratislava, Axon successfully tested the efficacy of these therapeutic antibodies on the live SARS-CoV-2 virus
Axon has begun preparing these potential therapeutic antibodies for the humanisation process, which is required to start human clinical trials

BRATISLAVA, SOLVAKIA / ACCESSWIRE / November 25, 2020 / AXON Neuroscience ("Axon"), a clinical-stage biotech company and a world leader in the development of tau vaccines for therapy and prevention against Alzheimer's Disease, announced today that it successfully tested therapeutic antibodies on the live SARS-CoV-2 virus.

Axon generated these antibodies, which can prevent the SARS-CoV-2 virus from reproducing, in the course of developing its prophylactic COVID-19 vaccine ACvac1 ("COVIDAX"). Using antibodies that demonstrated strong efficacy in several independent tests, Axon was able to map the most vulnerable parts of the virus, which are then detectible by the human immune system.

Norbert Žilka, the Chief Scientific Officer of Axon, said: "Some of these antibodies were able to completely eliminate the virus, showing their therapeutic potential. We have subsequently demonstrated their efficacy in a number of other conceptually different tests that we have developed in our laboratories. We will now focus on the process of humanisation, in order to start the production process, which is necessary to begin the clinical trials."

Michal Fresser, CEO of Axon, added: "Axon's research program is based on 20+ years of innovative, and at times seemingly unconventional, research and development that has led to major breakthroughs. We are delighted to announce that we have successfully identified antibodies with a potential therapeutic effect in patients diagnosed with COVID-19. We have a two-pronged goal: to continue developing our preventive COVIDAX vaccine to immunize vulnerable populations; and, in parallel, to develop a drug that can halt and mitigate the COVID-19 virus in those infected. This would have the potential to flatten the curve and take pressure off overburdened health care systems. We have decided to open the project to interested investors through crowdfunding (www.covidax.eu) because we would like to stay independent and continue our research program unaffected by political or industry pressure."

ACmab1 (COVIMAX) – neutralising antibodies against COVID-19

ACmab1 is a therapeutic candidate intended to treat those infected with COVID-19. The antibodies show the ability to target vulnerable parts of the S-protein of the virus, in order to stop the virus from interacting with host cells and replicating.

Testing the antibodies was done at the laboratories of the Virological Institute of Biomedical Research Center at the Slovak Academy of Sciences in Bratislava. The efficacy of the selected antibody candidates was tested directly on the live SARS-CoV-2 virus on cell cultures. Results from these tests show that the antibodies are able to efficiently stop the interaction of virus with the host cell and stop its further reproduction.

RNDr. Boris Klempa, DrSc, Virological Institute, BMC of SAS added: "In our cooperation with Axon, we are utilising the plaque-reduction neutralization test. This test is performed in our specialized laboratory compliant with a 3rd degree of Biosafety Level requirements ("BSL3"), as we are working directly with the infectious virus SARS-CoV-2 (in the form of our isolate BMC5). Tests are being performed in a strictly blinded mode; our team receives only numbered samples, which we then evaluate based on their ability to neutralize the virus. We have identified a strongly neutralizing ability in several of these blinded samples."

About Axon Neuroscience

Axon Neuroscience is an industry leading, clinical stage biotech company and an innovator in the development of peptide vaccines against so-far incurable brain diseases. The company was founded in 1999 and now has the single biggest team in the world dedicated exclusively to peptide vaccine development for treating Alzheimer's Disease. The work of the Axon team is regularly published in top-tier scientific journals and publications, including Lancet Neurology and Neurology.

Axon's lead vaccine AADvac1 is the most clinically-advanced tau therapy in development for treating and preventing Alzheimer's Disease. In late 2019, Axon successfully completed a Phase 2 clinical trial in almost 200 Alzheimer's patients, which revealed excellent safety, immunogenicity and efficacy. The evidence from its clinical trials on Alzheimer's disease proved its peptide-based vaccine platform to be very safe and well-tolerated. Over 80% of the treated Alzheimer's patients demonstrated an exceptional immune response and generated a robust quantity of antibodies. The therapy was able to significantly slow down the process of neurodegeneration in treated patients by almost 60%.

Axon's extensive knowledge in producing safe and immunogenic vaccines and well-established scalable technology allowed it to move very quickly in creating its novel peptide vaccine against COVID-19.

Note: Axon's share issue available through dedicated website (www.covidax.eu) is available to investors in a number of European countries under the European Prospectus Regulation. A complete list of approved Prospectus extracts for each of the selected countries is published on our website.

— The End —

George Salapa
AXON Neuroscience
media@axon-neuroscience.eu

SOURCE: AXON Neuroscience SE

ReleaseID: 618184

VALLETTA, MALTA / ACCESSWIRE / November 25, 2020 / The DeFi sector continues to see expansion in all aspects. According to recent reports, the market currently holds over $6 billion in value locked in smart contracts. Impressively, this growth is increasing in both its scope and rate. There are now more products, protocols, and platforms than ever in the market. This ever-growing diversity can make finding the best platforms a real choir.

At the current rate of entry, you would need to put aside some serious time and effort to get even the smallest grasp of the market. Complicating matters is the fact that there are new financial instruments being developed daily. These new systems provide more opportunity but also make understanding DeFi an ever-growing challenge.

Luckily, there are some DeFi projects that deserve your attention for their unique approach. These platforms introduce proprietary technologies and business models to eliminate some of the most pressing issues facing the market currently. From staking and lending for profits to eliminating centralization, DeFi is impressive. Here are 4 unique DeFi Projects to watch for the end of 2020

The Force Protocol

The Force Protocol is an add-on that works across the DeFi sector. This extra package for decentralized finance was designed to rectify some of the inherent issues developers and users encounter on the Ethereum network. Specifically, the Force Protocol streamlines contract upgrades, fixes data structure issues, removes slow on-chain interactions, and poor user experience due to a lack of necessary infrastructure.

The Force Protocol consists of a set of DeFi technical components and tokenized protocols that simplify the core functionalities of DeFi investing. The platform provides users with secure, inclusive, innovative, and transparent blockchain-based financial services. Additionally, the system introduces solutions for cross-platform transactions, stable coin issues, and on-chain payments

The Force Protocol relies on three DeFi technical components that all interact to accomplish the platform's goal. These components include fundamental components, extension components, and financial components. Together, these tools create a highly usable DeFi interface geared towards all user types.

Synthetix

Synthetix is a decentralized investment platform that brings new capabilities to the market. The platform's main characteristic is its ability to create Synths. Synths are on-chain representations of real-world assets. These synthetic versions of real-world assets can then be traded on a peer-to-peer basis.

This decentralized, non-custodial, multi-token infrastructure provides users with an impressive variety of DeFi protocols. Users can earn profits via staking, inflation, and fees. The SNX token makes it all possible. SNX is staked as collateral to potentially create any synthetic asset that resides on the platform. In this way, users can trade nearly anything from stocks like Tesla and Apple, to debt-equity on top of Ethereum.

Importantly, Synthetix recently partnered with Chainlink to ensure that its network provides the most up-to-date pricing metrics. ChainLink is another popular project that hosts a blockchain of oracles. Oracles are off-chain sensors that can send and receive data from a blockchain.

DeFi Yield Protocol (DYP)

The DeFi Yield Protocol (DYP) removes whale manipulation from the DeFi space forever. DYP takes care of this concern by integrating a DYP anti-manipulation feature that ensures that the rewards from supported tokens (DYP/ETH, DYP/USDC, DYP/USDT, and DYP/WBTC POOL) are automatically converted from DYP to ETH at 00.00 UTC. Also if the price of DYP is affected by more than -2.5 then the maximum DYP amount that does not affect the price will be swapped to ETH, with the remaining amount distributed in the next day rewards.

DYP Finance offers a utility token that enables users to interact with the features on the DYP smart contract. Ethereum miners can join the DYP mining pool and get rewarded monthly with a 10% bonus from the ETH monthly income earned by the pool. The automated Earn Vault will distribute 75% of profits to liquidity providers while the 25% left will be used to buy back their protocol token to add liquidity and maintain token price stability.

DYP features a decentralized governance protocol that helps the network to maintain a strong community of users engaged in the platform's development. Interestingly, the community gets to vote on whether to burn or reward users with the DYP tokens the anti-manipulation protocol secures. This level of community participation is one of the best aspects DeFi brings to the market.

NFTfi

NFTfi is a hybrid platform that takes the best aspects of DeFi and combines them with the growing value of the non-fungible token (NFTs) sector. NFTs are blockchain verifiable collectors. The most popular form of NFT is ERC-721 tokens. Examples of valuable NFTs include tokens from Gods Unchained, Decentraland, Cryptovoxels, and Cryptokitties. These tokens are also what's used to verify digital artwork.

Users can stake their NFTS and receive loans using NFTs as collateral. This strategy allows anyone who owns inactive or unused digital assets to use them to get short term crypto loans. When users repay this loan with interest, their NFT is unlocked.

Lenders can browse through the selection of NFTs available at any time. Once they find an NFT they are willing to lend against the process is simple. They select the amount they are willing to lend and make an offer to the borrower. If the offer is accepted, the NFT gets locked in a smart contract. If the borrower is unable to repay the loan, the lender gets to keep the NFT.

4 Unique DeFi Projects to Watch for the End of 2020

The rise of DeFi introduces some new and exciting ways to earn free crypto. The key to success is to only stick with reputable platforms like the ones listed above and you are sure to achieve your desired ROIs. DeFi may be new, but the profits its producing are enough to motivate continued adoption for years to come. As the year starts to close out, there's no reason to slack on your investment strategy.

Contact:

Teki Kolaneci – Digital Strategy Manager
Company: DYP FInance
Address: Malta, Valeta
Phone: 07355050442
Email: contact@dyp.finance
Website: https://dyp.finance

SOURCE: DYP Finance

ReleaseID: 618345

GEORGE TOWN, GRAND CAYMAN / ACCESSWIRE / November 25, 2020 / Orion Terminal, the first decentralized gateway to the entire cryptocurrency market, is preparing for a major milestone with the first phase of its public mainnet scheduled to launch on December 15.

By seamlessly aggregating liquidity from all major centralized and decentralized exchanges and swap pools into a single orderbook, Orion Terminal offers traders a simple, convenient gateway to trading and eliminates the need to surrender their private keys.

Orion Protocol's ecosystem is built on a network of brokers running Orion Broker Software with accounts across multiple exchanges (or exchanges themselves, including BitMax, KuCoin, MXC, Injective Protocol, and others).In recent months, the defi platform has conducted rigorous testing among a closed group of brokers on their private main net in a bid to ensure smooth functionality and robust security. CertiK, a leading security firm, has also audited the Orion Terminal mainnet in advance and confirmed its stability.

Platform updates will be continually rolled out over the month following the launch of Orion Terminal. Meanwhile, Orion Protocol has ambitious plans for the terminal in 2021, expanding its offering into lending, margin trading, leveraged ETFs, derivatives, contract trading, NFTs, and staking of any asset type. Staking of Orion Protocol's native ORN token will be available on the platform in early Q1.

At the core of Orion Protocol is its native ORN token, providing holder benefits such as discounted trading, advanced features, protocol access, and staking returns.

"The launch of Orion Terminal's mainnet has been a vision of ours since Orion Protocol's inception in 2018, and we're ecstatic that we're almost here " says Alexey Koloskov, Chief Executive Officer of Orion Protocol.

"Having spent several years developing the protocol, we're incredibly excited to take our first step towards revolutionizing trading. . Users will be able to trade with the liquidity of the entire crypto market in one place, while the aggregated order books of every exchange in market will guarantee the best price, every time, with almost zero spread and zero slippage across thousands of trading pairs. Best of all, users have access to all of this and more without the need to ever give up their private keys, trading directly from their wallet."

About Orion Protocol

Built on the most advanced liquidity aggregator ever developed, Orion Protocol aggregates the liquidity of every single crypto exchange into one platform: providing a decentralized gateway to the entire digital asset market. In doing so, Orion is building a protocol on which to bridge the worlds of crypto, traditional finance, and real world assets.

Media Contact

Tal Harel, MarketAcross
Tal@MarketAcross.com

SOURCE: Orion Protocol

ReleaseID: 618343

NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Real estate is one of the busiest scenes in the world. Experts and professionals in the industry have to keep up with trends to have the upper hand. Bòunyadej Q. Sànanikone is one of the most well-versed real estate sales professionals and has taken his skills from his native country of Laos to New York City in the United States to improve the real estate market in his way.

Bòunyadej Sànanikone comes from an influential political and real estate family. Like many others in his family, he chose to pursue a different path by following a real estate career and set himself apart while at it. His great-grandfather, Phoui Sànanikone, is the first Laotian Politician to have held multiple positions from Prime Ministership to Foreign Affairs Minister. The legendary Sànanikone family is often referred to as the Rockefellers and the Kennedys of Laos. They are having to own various businesses stemming from pharmaceuticals, aerospace, and real estate.

The name Sànanikone is a well-respected name in Asia. While Mr. Sànanikone may not be pursuing a political career, he is carrying on the family name by excelling in a field that everyone in the world is connected to.

(1959 Press Photo UN Secretary-General Dag Hammarskjold (right) with His Excellency Prime Minister Phoui Sananikone (left).

Mr. Sànanikone has a strong background in risk-adjustment investments as a licensed, accredited investment professional from Adagio Group. He is also an expert luxury real estate marketer with modern marketing skills and access to analytical data. The blandness and boringness informed his move to New York real estate. In his words, "There isn't a broker in this city that can harness the power of basic analytics coupled with alternative marketing toward buyers and viewers. I want to make real estate buying decisions fun and exciting. I compose real estate analytics into a fun and modern understanding of marketing."

He started his career at The Norasing Group, a firm owned by his maternal grandfather. At the firm, Sànanikone completed more than ten OHDACA government-projects, and now all that expertise is being pumped into his real estate team in New York, The Sananikone Group NYC.

Sànanikone's goal is to make real estate buying decisions a lot easier and more fun for the players. His ability to blend traditional finance and complex risk-adjusted returns to make purchases happen and go smoothly is one of the rarest skills in the industry. With his team, he translates raw data and risk-adjusted return metrics to amaze buyers, strike a connection, and get them to buy.

He has more than 30,000 followers on social media through which he targets and markets to real estate developers, sales teams, and brokerages. Making sales happen is his specialty, and he plans to grow his team to the point where he handles the highest volume of real estate transactions in New York. "I will become the #1 Real Estate Broker and have the #1 real estate sales team in New York City. I am an expert at marketing new development residential properties and private clients who want to sell their properties."

Through his team, the Sananikone Group NYC, Bòunyadej Q. Sànanikone aims to change the way real estate marketing is done while also giving buyers a new approach to making decisions.

Learn more about Bòunyadej Q. Sànanikone on his Instagram page.

Company: The Sananikone Group NYC
Office Number: (212)-220-6030
Email: q@sananikonegroup.com
Website:https://www.instagram.com/bounyadej/

SOURCE: The Sananikone Group NYC

ReleaseID: 618320

World Artists United Who Produces the Music Entrepreneur Conference Coming Up on December 11 and 12th 2020 Is Partnering With the Music Fund to Provide Up to $500,000 to Artists and Labels

NEW ORLEANS, LA AND NEW YORK, NY / ACCESSWIRE / November 24, 2020 / Yet another key leader in music who puts serious cash in the hands of rising artists and music-rights holders has been added to the Music Entrepreneur family.

Over the years, the conference has been bringing together business leaders and personal development professionals who know what it takes to build strong brands, connected teams and growth strategies that allow music entrepreneurs to break barriers and develop sustainable careers.

"One challenge we always seemed to face was in finding financial resources for growth," says Rachel Karry, the co-founder of Music Entrepreneur. "If you don't want to sign to a label, give control to an investor and don't have a wealthy aunt willing to cut you a check for your crazy dream, there seem to be few financial options to move your career forward. We dreamt of a "music bank" our community could tap into. And then we found The Music Fund! We now have over $500,000 for creators to get to the next level."

The Music Fund provides an automated platform that uses a data-driven smart-pricing algorithm to offer up-front cash for a portion of any artist's royalty stream income. The founders behind the company created an investment fund that allows investors to help rising artists meet their needs in an artist-first and scalable way. The company is breaking down the artist-funding hurdle by solving multiple financing headaches associated with the delay in accessing income generated from streaming.

Rights holders stay in control of their future. Once The Music Fund makes them an offer, they decide what percentage of their music royalties they feel comfortable sharing. Based on the streaming data acquired over the last two years, The Music Fund offers up to $50,000 per deal. Rights holders receive cash simply by sharing one percent or more of their master-royalty earnings, and after two years, 100% of the rights holders' ownership is given back and the deal is over. No one owns an artist's hard work but them!

The Music Fund recommends that artists who apply have a minimum of 100,000 monthly streaming-service listeners, but those with as few at 10,000 are encouraged to apply and find out how much money they are eligible for. Funding is available to artists, producers, indie labels, managers and anyone else who has streaming royalties, and can be offered in as little as one day. Test the company's payment-calculation formula via Playground and see how it works at www.TheMusic.fund

"What we really love about TMF is that they are the first company to put their money where their mouth is" says Karry. Once The Music Fund sends money to someone, they won't ask for even $1 back regardless of how much they end up collecting over the two-year period. It's not like a label advance with loopholes where an artist is on the hook to pay back an advance or required to create music they won't own. If TMF doesn't make a return on their investment, it's their loss. TMF is also only tapping into the back catalogue, so artists can create more music for the future and own 100% of it. "This is a key component in building the future of the music industry," says Karry. "The days when artists had little creative control and kept a mere 15% ownership of their own music are over."

"By making a large number of small bets we simply hope we get it right on average, and the artist wouldn't be on the hook if we get it wrong," says John Funge, Founder and CEO of The Music Fund. "As we test out this new approach to support music entrepreneurs, we are committed to being socially responsible and creating a model that helps creators self-direct their career."

Let's say someone gets to put cash in their pocket, then what? Music Entrepreneur and its parent company World Artists United are putting simple solutions and industry pros at the fingertips of these creative entrepreneurs to guide them in making the most of that money. "We've been building partnerships around the world with the brightest business leaders and tech innovators in music, from those building next-level websites that allow artists to efficiently grow and track their fanbase, to marketing experts who can help them release their next single like a pro, and ecommerce rock stars who will help them generate sales," says Karry.

The Music Fund isn't stopping there, however, by partnering with Oasis Labs, a pioneering privacy paradigm that protects and keeps music data anonymous, the fund has created a privacy-first framework that will allow artists to take control of their own data (including Spotify streaming data, royalty earnings data, social media stats, and data from Facebook ads) and choose how and who to safely share it with. Artists will be able to securely upload their data to the data-sharing platform built on top of Oasis Labs' privacy-preserving blockchain and selectively grant access to companies that provide services they are interested in. Artists will be able to see who is accessing their data and revoke access at any time.

For everyone who applies, MEcon will also be providing a complimentary ticket to the conference and hosting special workshops, courses and mastermind groups that take music marketing and business development strategy to the next level.

To apply for funding, visit themusic.fund/WAU and receive an extra $50 with your offer.

Learn more about Music Entrepreneur at www.musicentrepreneurconference.com

And, World Artists United at www.Worldartistsunited.com

Contact Info:
Name: Kwasi Asare
Email: Send Email
Organization: World Artists United
Address: 838 North Rampart Street, New Orleans, Louisiana 70116, United States
Website: https://www.worldartistsunited.com/

SOURCE: World Artists United

ReleaseID: 618327